The functional importance of NAIP in immunogenic modulation was confirmed by demonstrating that a reduction in NAIP, whether mediated by treatment with enzalutamide or NAIP siRNA, in either AR+ or AR− prostate cancer cells, improved the cells' sensitivity to T cell-mediated killing (Fig. 5). This evidence concerns the gene AR and prostate carcinoma.